News & Press Releases

Yseop Featured in mind Health: Accelerating Drug Approvals with Regulatory-Grade AI

Yseop was recently featured in mind Health, where Pierre-Louis Durel, VP Strategy & Operations, shared how AI is transforming regulatory writing—and why it is becoming a critical lever for accelerating access to new therapies.

Share This Post

Originally founded in 2007, Yseop first developed natural language generation solutions for financial services. The company made a strategic shift to life sciences, driven by a clear need: helping pharmaceutical companies automate the creation of regulatory documents such as Clinical Study Reports (CSRs).

Today, Yseop supports medical writers and scientists across more than 300 clinical trials, working with leading pharmaceutical companies worldwide.

From automating complex documents like Clinical Study Reports to achieving 50% productivity gains and accelerating submissions by several weeks—with a roadmap to months—this interview highlights how Yseop’s Regulatory-Grade AI is moving from experimentation to large-scale adoption.

Read the full interview to discover how leading pharma companies are leveraging AI to scale regulatory operations here.

Scroll to Top